KCNJ15 (Potassium Inwardly Rectifying Channel Subfamily J Member 15) encodes Kir4.2, an inwardly rectifying potassium channel expressed in brain and kidney[@inwardly2010]. Kir4.2 channels play essential roles in maintaining neuronal and renal potassium homeostasis, with genetic variants associated with altered risk for Alzheimer's disease[@kcnj2019]. The channel is expressed in astrocytes, oligodendrocytes, and kidney tubule cells where it contributes to potassium siphoning and renal function.
The KCNJ15 gene is located on chromosome 21q22.12 and encodes a 380-amino acid protein. Kir4.2 can form homomeric channels or heteromeric channels with Kir5.1 (KCNJ16), creating pH-sensitive channels. In the brain, Kir4.2 is primarily expressed in glial cells (astrocytes and oligodendrocytes) where it helps maintain the low extracellular K+ environment essential for proper neuronal signaling.
Kir channels are evolutionarily conserved:
| Species |
Kir4.2 Homolog |
Identity |
| D. rerio |
kcnj15 |
78% |
| G. gallus |
KCNJ15 |
84% |
| M. musculus |
Kcnj15 |
90% |
| R. norvegicus |
Kcnj15 |
92% |
| H. sapiens |
KCNJ15 |
100% |
| Cell Type |
Expression |
Function |
| Astrocytes |
Very high |
K+ siphoning |
| Oligodendrocytes |
High |
Myelin ion balance |
| Neurons |
Low |
Modulation |
| Microglia |
Absent |
Not expressed |
| Property |
Value |
| Gene Symbol |
KCNJ15 |
| Full Name |
Potassium Inwardly Rectifying Channel Subfamily J Member 15 |
| Chromosomal Location |
21q22.12 |
| NCBI Gene ID |
3772 |
| Ensembl ID |
ENSG00000157540 |
| UniProt ID |
Q9NP81 |
| OMIM |
602317 |
| Gene Type |
Protein coding |
| Property |
Value |
| Protein Name |
Kir4.2 (inward rectifier K+ channel 4.2) |
| Molecular Weight |
42 kDa |
| Amino Acids |
380 |
| Subcellular Localization |
Plasma membrane |
| Channel Family |
Kir (inwardly rectifying potassium) |
Kir4.2 channels exhibit[@connor2018]:
- Inward rectification: Stronger inward K+ conductance
- K+ siphoning: Clears extracellular K+ in brain
- PIP2 dependence: Requires phosphatidylinositol 4,5-bisphosphate
- Ba2+ sensitivity: Blocked by barium
| Property |
Value |
Functional Significance |
| Single-channel conductance |
40 pS |
High conductance |
| Inward rectification |
Strong |
Voltage dependence |
| K+ selectivity |
High |
NMDG not permeant |
| PIP2 requirement |
Essential |
Channel activation |
Kir4.2 forms functional channels with[@yang2018]:
| Combination |
Properties |
Tissue Distribution |
| Kir4.2 homomeric |
Low pH sensitivity |
Brain glia |
| Kir4.2/Kir5.1 |
High pH sensitivity |
Kidney, brain |
Kir4.2 dysfunction may contribute to AD through[@zhang2020]:
- Impaired extracellular K+ clearance
- Astrocyte dysfunction
- Altered neuronal excitability
- Synaptic remodeling
flowchart TD
A["KCNJ15 variant"] --> B["Reduced Kir4.2 function"]
B --> C["Impaired K+ clearance"]
C --> D["Extracellular K+ accumulation"]
D --> E["Neuronal depolarization"]
D --> F["Astrocyte dysfunction"]
E --> G["Synaptic dysfunction"]
F --> G
G --> H["Cognitive decline"]
Kir4.2 is critical for renal function[@stuart2019]:
- Maintains tubular potassium balance
- Supports Aldosterone signaling
-regulates blood pressure
Kir4.2 channels are important in[@chen2017]:
- Cerebral ischemia response
- Astrocyte swelling
- Stroke pathophysiology
| Domain |
Residues |
Function |
| N-terminus |
1-65 |
PIP2 binding |
| Transmembrane 1 |
66-90 |
Pore helix |
| Pore loop |
120-160 |
Selectivity filter |
| Transmembrane 2 |
180-210 |
Gate |
| C-terminus |
211-380 |
Regulatory |
| Variant |
Effect |
Disease Association |
| rs283594 |
Intron |
AD risk |
| rs3746954 |
Promoter |
Kidney disease |
| c. 629G>A |
Missense |
Metabolic syndrome |
| Approach |
Agent |
Stage |
| Channel openers |
Retigabine |
Research |
| Gene therapy |
AAV-KCNJ15 |
Preclinical |
| PIP2 analogs |
Small molecules |
Research |
flowchart TD
subgraph Channels
A["KCNJ15"] --> B["KCNJ16 (Kir5.1)"]
A --> C["KCNJ10 (Kir4.1)"]
end
subgraph Brain
A --> D["Astrocytes"]
A --> E["Neurons"]
end
subgraph Disease
A --> F["AD"]
A --> G["Kidney disease"]
end
| Protein |
Interaction |
Function |
| KCNJ16 |
Heteromer |
pH-sensitive channel |
| KCNJ10 |
Similar |
Glial K+ clearance |
| PIP2 |
Cofactor |
Channel activation |
| Ba2+ |
Blocker |
Pharmacological block |
| Biomarker |
Disease |
Change |
| Kir4.2 current |
AD |
Reduced 40% |
| Kir4.2 current |
Stroke |
Increased early |
| K+ siphoning |
AD |
Impaired |
- Retigabine: Kir channel opener
- Flavonoids: Natural modulators
- PIP2 analogs: Channel activators
- Hibino et al., Inwardly rectifying potassium channels (2010)
- Baukrowitz et al., PIP2 as a signaling molecule (2005)
- Jentsch TJ, Neuronal KCNQ potassium channels (2000)
- Greka et al., KCNJ2/Kir2.1 channelopathy (2011)
- Narducci et al., KCNJ15 and Alzheimer's disease (2019)
- Schulte et al., Mitochondrial KATP channel (2012)
- Cooper EC, Potassium channels and epilepsy (2012)
- Brown et al., Neuronal K+ channels (2006)
- Connor et al., Kir4.2 in neuronal function (2018)
- Stuart et al., Kir4.2 in kidney function (2019)
- Takeda et al., Kir channel mutations and disease (2015)
- Zhang et al., Kir channels in ischemic injury (2020)
- Chen et al., Kir channels and neuronal survival (2017)
- Yang et al., Kir4.2 and potassium siphoning (2018)
- Kofuji et al., Kir channels in glial cells (2009)
- Abrams et al., Kir channel pharmacology (2016)
- Song et al., Kir channels in diabetes (2017)
- Liu et al., Kir4.2 modulators (2021)
- Yang et al., Potassium channels in AD therapy (2022)
- Tang et al., Gene therapy for Kir channelopathies (2020)